Literature DB >> 26291510

Secretory Breast Carcinoma: A Histopathologic and Genomic Spectrum Characterized by a Joint Specific ETV6-NTRK3 Gene Fusion.

Marie Del Castillo1, Frédéric Chibon, Laurent Arnould, Sabrina Croce, Agnès Ribeiro, Gaëlle Perot, Isabelle Hostein, Sameh Geha, Catherine Bozon, Agnès Garnier, Marick Lae, Anne Vincent-Salomon, Gaëtan MacGrogan.   

Abstract

Secretory breast carcinoma (SBC) is a rare breast carcinoma with distinctive morphologic features and a recurrent specific chromosomal translocation t(12;15)(p13;q25), usually of low histologic grade and favorable prognosis. We describe the morphologic and genetic characteristics of 11 cases of SBC from 10 patients. Histologic and immunohistochemical analyses, fluorescence in situ hybridization using break-apart probes specific to ETV6 on 12p13, reverse transcription polymerase chain reaction with in-house probes specific to the ETV6-NTRK3 gene fusion, and DNA copy number variation by array comparative genomic hybridization analyses were performed on all cases. Seven cases were of low histologic grade, 3 were intermediate, and 1 had high-grade nuclear atypia, necrosis, and numerous mitoses. This patient had a fatal outcome. Five cases displayed low hormonal receptor expression, whereas the rest had basal-type immunoprofiles. All interpretable cases harbored an ETV6-NTRK3 gene fusion by reverse transcription polymerase chain reaction and/or an ETV6 rearrangement by fluorescence in situ hybridization, with duplication of the oncogenic derivative in 2 cases. Array comparative genomic hybridization analysis showed simplex genomic profiles. The 2 cases with ETV6-NTRK3 duplication included a gain of 12p starting from the ETV6 locus to the telomere, associated with a gain of the 15q from the centromere to NTRK3 in 1 case, and in the other a normal profile up to NTRK3 on 15q, and then a loss up to the telomere, suggesting loss of corresponding normal chromosome 15. These findings provide a novel insight into the morphologic and genetic spectrum of SBC, ranging from low-grade to high-grade histology, with occasional low hormonal receptor expression, simplex genomic profiles, and possible unfavorable course.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26291510     DOI: 10.1097/PAS.0000000000000487

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  25 in total

Review 1.  Emerging Gene Fusion Drivers in Primary and Metastatic Central Nervous System Malignancies: A Review of Available Evidence for Systemic Targeted Therapies.

Authors:  Priscilla K Brastianos; Franziska Maria Ippen; Umbreen Hafeez; Hui K Gan
Journal:  Oncologist       Date:  2018-04-27

Review 2.  Molecular Classification and Future Therapeutic Challenges of Triple-negative Breast Cancer.

Authors:  Nikolaos Garmpis; Christos Damaskos; Anna Garmpi; Konstantinos Nikolettos; Dimitrios Dimitroulis; Evangelos Diamantis; Paraskevi Farmaki; Alexandros Patsouras; Errika Voutyritsa; Athanasios Syllaios; Constantinos G Zografos; Efstathios A Antoniou; Nikos Nikolettos; Alkiviadis Kostakis; Konstantinos Kontzoglou; Dimitrios Schizas; Afroditi Nonni
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

Review 3.  The Spectrum of Triple-Negative Breast Disease: High- and Low-Grade Lesions.

Authors:  Felipe C Geyer; Fresia Pareja; Britta Weigelt; Emad Rakha; Ian O Ellis; Stuart J Schnitt; Jorge S Reis-Filho
Journal:  Am J Pathol       Date:  2017-07-20       Impact factor: 4.307

4.  Genomic profiling of breast secretory carcinomas reveals distinct genetics from other breast cancers and similarity to mammary analog secretory carcinomas.

Authors:  Gregor Krings; Nancy M Joseph; Gregory R Bean; David Solomon; Courtney Onodera; Eric Talevich; Iwei Yeh; James P Grenert; Elizabeth Hosfield; Emily D Crawford; Richard C Jordan; Annemieke van Zante; Charles Zaloudek; Sandra J Shin; Yunn-Yi Chen
Journal:  Mod Pathol       Date:  2017-05-26       Impact factor: 7.842

Review 5.  AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2022.

Authors:  Nina Ditsch; Achim Wöcke; Michael Untch; Christian Jackisch; Ute-Susann Albert; Maggie Banys-Paluchowski; Ingo Bauerfeind; Jens-Uwe Blohmer; Wilfried Budach; Peter Dall; Eva Maria Fallenberg; Peter A Fasching; Tanja N Fehm; Michael Friedrich; Bernd Gerber; Oleg Gluz; Nadia Harbeck; Jörg Heil; Jens Huober; Hans H Kreipe; David Krug; Thorsten Kühn; Sherko Kümmel; Cornelia Kolberg-Liedtke; Sibylle Loibl; Diana Lüftner; Michael Patrick Lux; Nicolai Maass; Christoph Mundhenke; Ulrike Nitz; Tjoung-Won Park-Simon; Toralf Reimer; Kerstin Rhiem; Achim Rody; Marcus Schmidt; Andreas Schneeweiss; Florian Schütz; Hans-Peter Sinn; Christine Solbach; Erich-Franz Solomayer; Elmar Stickeler; Christoph Thomssen; Isabell Witzel; Volkmar Müller; Wolfgang Janni; Marc Thill
Journal:  Breast Care (Basel)       Date:  2022-05-05       Impact factor: 2.268

Review 6.  Emerging Therapeutics for Patients with Triple-Negative Breast Cancer.

Authors:  Elisa Agostinetto; Daniel Eiger; Kevin Punie; Evandro de Azambuja
Journal:  Curr Oncol Rep       Date:  2021-03-24       Impact factor: 5.075

7.  Genetic analysis of microglandular adenosis and acinic cell carcinomas of the breast provides evidence for the existence of a low-grade triple-negative breast neoplasia family.

Authors:  Felipe C Geyer; Samuel H Berman; Caterina Marchiò; Kathleen A Burke; Elena Guerini-Rocco; Salvatore Piscuoglio; Charlotte Ky Ng; Fresia Pareja; Hannah Y Wen; Zoltan Hodi; Stuart J Schnitt; Emad A Rakha; Ian O Ellis; Larry Norton; Britta Weigelt; Jorge S Reis-Filho
Journal:  Mod Pathol       Date:  2016-10-07       Impact factor: 7.842

Review 8.  Novel uses of immunohistochemistry in breast pathology: interpretation and pitfalls.

Authors:  Ashley Cimino-Mathews
Journal:  Mod Pathol       Date:  2020-10-27       Impact factor: 7.842

Review 9.  Secretory carcinoma of the breast with multiple distant metastases in the brain and unfavorable prognosis: a case report and literature review.

Authors:  Hongping Tang; Lihua Zhong; Hongbing Jiang; Yan Zhang; Guannan Liang; Guoyan Chen; Gui'e Xie
Journal:  Diagn Pathol       Date:  2021-06-24       Impact factor: 2.644

10.  Multidisciplinary consensus on optimising the detection of NTRK gene alterations in tumours.

Authors:  P Garrido; R Hladun; E de Álava; R Álvarez; F Bautista; F López-Ríos; R Colomer; F Rojo
Journal:  Clin Transl Oncol       Date:  2021-02-23       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.